GOLDMAN SACHS GROUP INC - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 15 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$8,000
-93.6%
13,755
-83.6%
0.00%
Q1 2017$125,000
+135.8%
84,006
+724.5%
0.00%
Q3 2015$53,000
-47.5%
10,189
-19.7%
0.00%
Q2 2015$101,000
-36.5%
12,690
-26.6%
0.00%
Q1 2015$159,00017,2900.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Puissance Capital Management LP 8,298,755$17,261,00014.88%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 15,138,486$31,488,0002.58%
VHCP Management II, LLC 4,149,378$8,631,0002.08%
Boxer Capital, LLC 1,857,143$3,863,0000.41%
Telemetry Investments, L.L.C. 199,000$414,0000.16%
EAM Investors, LLC 232,290$483,0000.08%
DRW Securities, LLC 70,000$146,0000.01%
Renaissance Technologies 1,032,900$2,148,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 23,000$48,0000.00%
STATE STREET CORP 13,800$29,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders